title: [Emergency treatment and management of anaphylaxis].
abstract: Anaphylaxis, the maximal manifestation of an immediate allergic reaction, is a life-threatening systemic reaction. The immediate therapy is chosen according to the clinical manifestations and new German guidelines are in preparation. Required measures include immediate removal of allergen, adequate positioning, assessment of severity and organ involvement and activation of emergency medical services. In anaphylaxis with primarily cardiovascular involvement, epinephrine is the treatment of choice and given together with volume substitution, oxygen, H(1)-antihistamines and corticosteroids. Obstruction of the airways is treated with intramuscular and inhaled epinephrine, or alternatively β(2)-sympathicomimetics, and oxygen. Abdominal or cutaneous involvement, such as generalized urticaria, usually can be treated with intravenous H(1)-antihistamines, glucocorticoids and surveillance. In patients with anaphylaxis, the elicitor of the reaction has to be diagnosed by allergy testing. Patients with sustained risk for anaphylaxis should receive a self-medication kit and should be educated about behavioral patterns needed for prophylaxis and therapy of anaphylactic reactions. Patient educational intervention increases knowledge about anaphylaxis, and practical competence and thus, is a basis of a successful management of anaphylaxis.
authors: Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein und Zentrum Allergie und Umwelt GSF/TUM, Technische Universität München. knut.brockow@lrz.tum.de
authors: K
authors: K
authors: Brockow
authors: J
authors: J
authors: Ring
mesh_terms: D000280:Administration, Inhalation; D000402:Airway Obstruction / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D000465:Algorithms; D000707:Anaphylaxis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D001249:Asthma / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003131:Combined Modality Therapy; D004632:Emergency Medical Services / Q000379:methods*; D004837:Epinephrine / Q000008:administration & dosage / Q000627:therapeutic use; D005440:Fluid Therapy / Q000379:methods; D006323:Heart Arrest / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D007819:Laryngeal Edema / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D010102:Oxygen Inhalation Therapy / Q000379:methods; D012151:Resuscitation / Q000379:methods
chemical_list: D006633:Histamine Antagonists; D004837:Epinephrine
references: J Allergy Clin Immunol. 1997 Oct;100(4):458-63
references: 9338537
references: Pediatr Allergy Immunol. 2012 Sep;23(6):506-8
references: 22906368
references: Allergy. 2010 Oct;65(10):1205-11
references: 20584003
references: Chem Immunol Allergy. 2010;95:201-210
references: 20519892
references: N Engl J Med. 2011 Jun 30;364(26):2543-4
references: 21615300
references: J Allergy Clin Immunol. 2011 Mar;127(3):587-93.e1-22
references: 21377030
references: J Allergy Clin Immunol. 2007 Jun;119(6):1550-1
references: 17481708
references: J Allergy Clin Immunol. 2010 Jul;126(1):83-91.e1
references: 20542324
references: J Allergy Clin Immunol. 2004 Aug;114(2):371-6
references: 15316518
references: Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):326-31
references: 21659863
references: J Allergy Clin Immunol. 2006 Feb;117(2):391-7
references: 16461139
references: Allergy. 2008 Mar;63(3):376-8
references: 18269681
references: J Allergy Clin Immunol. 2011 Mar;127(3):640-6.e1
references: 21281959
references: Curr Opin Allergy Clin Immunol. 2010 Aug;10(4):354-61
references: 20543673
references: Lancet. 1977 Feb 26;1(8009):466-9
references: 65572
references: Resuscitation. 2010 Oct;81(10):1219-76
references: 20956052
references: Allergy. 2008 Feb;63(2):226-32
references: 18186813
references: MMW Fortschr Med. 2006 Jul 20;148(29-30):28-31
references: 16910403